Contact
searchSearch
HMP Global

Meet the Experts

headshot of Doug Devens Doug Devens
headshot of Kris Flinn Kris Flinn
Headshot of Jay Merkel Jay Merkel
Headshot of Susan Paquette Susan Paquette
headshot of Lennart Stalder Lennart Stadler
Headshot of Anikó Szekér Anikó Szekér

 

Click here to learn more

SmartTrak x Wound Care Collaboration

Featured Commentaries

Feel the Pressure: Compression Trends for 2025
Blog
Feel the Pressure: Compression Trends for 2025
02/20/2025
SmartTRAK highlights the key trends in the US Compression Therapy market that will drive growth over the next few years.
SmartTRAK highlights the key trends in the US Compression Therapy market that will drive growth over the next few years.
SmartTRAK highlights the key...
02/20/2025
Wounds
Market Responds to Final MAC LCDs
Blog
Market Responds to Final MAC LCDs
01/08/2025
This blog was originally posted on SmartTrak's website on December 31, 2024: https://blog.smarttrak.com/market-responds-to-final-mac-lcds. Reposted with permission. SmartTRAK looks at the market’s response to the recently finalized...
This blog was originally posted on SmartTrak's website on December 31, 2024: https://blog.smarttrak.com/market-responds-to-final-mac-lcds. Reposted with permission. SmartTRAK looks at the market’s response to the recently finalized...
This blog was originally...
01/08/2025
Wounds
Facing the Payback Crisis: Challenges Threatening Italy’s Medical Device Sector
Blog
Facing the Payback Crisis: Challenges Threatening Italy’s Medical Device Sector
11/26/2024
In an interview with SmartTRAK, Gennaro Broya de Lucia, president of the National Board of Directors at PMI Sanità, offers a comprehensive summary of the challenges for the medical device market in Italy, which places hundreds of companies at...
In an interview with SmartTRAK, Gennaro Broya de Lucia, president of the National Board of Directors at PMI Sanità, offers a comprehensive summary of the challenges for the medical device market in Italy, which places hundreds of companies at...
In an interview with SmartTRAK,...
11/26/2024
Wounds
Reimbursement Changes: Wound Dressings Under Threat in Germany
Blog
Reimbursement Changes: Wound Dressings Under Threat in Germany
10/01/2024
In an interview with SmartTRAK, Dr. Willi Schnorpfeil, an expert in reimbursement strategies, offers a comprehensive overview of the regulatory changes for advanced wound care products in Germany, which pose a potential threat to both market...
In an interview with SmartTRAK, Dr. Willi Schnorpfeil, an expert in reimbursement strategies, offers a comprehensive overview of the regulatory changes for advanced wound care products in Germany, which pose a potential threat to both market...
In an interview with SmartTRAK,...
10/01/2024
Wounds
Skin Substitute Market Rocked by DOJ Investigations
Blog
Skin Substitute Market Rocked by DOJ Investigations
08/08/2024
SmartTRAK believes the billions of dollars of Medicare abuse already uncovered is the tip of the iceberg in services billed to Medicare via the Physician Fee Schedule.
SmartTRAK believes the billions of dollars of Medicare abuse already uncovered is the tip of the iceberg in services billed to Medicare via the Physician Fee Schedule.
SmartTRAK believes the billions...
08/08/2024
Wounds
Medicare Administrative Contractors' (MACs) LCD Changes: Impact on Skin Substitutes/CTPs
Blog
Medicare Administrative Contractors' (MACs) LCD Changes: Impact on Skin Substitutes/CTPs
05/29/2024
All seven MACs, in a united front, released proposed changes to the LCDs, which govern Skin Substitute/CTP use for DFUs and VLUs. SmartTRAK looks at the potential impact on the market.
All seven MACs, in a united front, released proposed changes to the LCDs, which govern Skin Substitute/CTP use for DFUs and VLUs. SmartTRAK looks at the potential impact on the market.
All seven MACs, in a united...
05/29/2024
Wounds
Vaporox Company Spotlight
Blog
Vaporox Company Spotlight
05/07/2024
This blog was originally posted on SmartTrak's website on May 2, 2024: https://blog.smarttrak.com/vaporox-company-spotlight. Reposted with permission. New leadership at Vaporox to launch a second generation of vaporous hyperoxia...
This blog was originally posted on SmartTrak's website on May 2, 2024: https://blog.smarttrak.com/vaporox-company-spotlight. Reposted with permission. New leadership at Vaporox to launch a second generation of vaporous hyperoxia...
This blog was originally...
05/07/2024
Wounds
Swedish Wound Care Companies – You Win Some, You Lose Some
Blog
Swedish Wound Care Companies – You Win Some, You Lose Some
04/10/2024
This blog was originally posted on SmartTrak's website on April 2, 2024: https://blog.smarttrak.com/swedish-wound-care-companies-you-win-some-you-lose-some. Reposted with permission. It is difficult to make it as a small to midsize...
This blog was originally posted on SmartTrak's website on April 2, 2024: https://blog.smarttrak.com/swedish-wound-care-companies-you-win-some-you-lose-some. Reposted with permission. It is difficult to make it as a small to midsize...
This blog was originally...
04/10/2024
Wounds
Preview Image
Blog
What Impact will GLP-1 Agonists have on Chronic Wounds?
03/18/2024
With many believing that GLP-1 agonists should be considered a “wonder drug,” SmartTRAK explores what impact their use could have on the market for wound care
With many believing that GLP-1 agonists should be considered a “wonder drug,” SmartTRAK explores what impact their use could have on the market for wound care
With many believing that GLP-1...
03/18/2024
Wounds
Preview Image
Partner Content
Advanced Wound Dressings: 2024 Market Outlook
03/05/2024
SmartTRAK forecasts the WW Advanced Wound Dressing Market will grow at a 5-year CAGR of +5.2%. The market grew +5.2% in Q323 and +5.6% in the first three quarters of 2023.
SmartTRAK forecasts the WW Advanced Wound Dressing Market will grow at a 5-year CAGR of +5.2%. The market grew +5.2% in Q323 and +5.6% in the first three quarters of 2023.
SmartTRAK forecasts the WW...
03/05/2024
Wounds
Feel the Pressure: Compression Trends for 2025
Blog
Feel the Pressure: Compression Trends for 2025
02/20/2025
SmartTRAK highlights the key trends in the US Compression Therapy market that will drive growth over the next few years.
SmartTRAK highlights the key trends in the US Compression Therapy market that will drive growth over the next few years.
SmartTRAK highlights the key...
02/20/2025
Wounds
Market Responds to Final MAC LCDs
Blog
Market Responds to Final MAC LCDs
01/08/2025
This blog was originally posted on SmartTrak's website on December 31, 2024: https://blog.smarttrak.com/market-responds-to-final-mac-lcds. Reposted with permission. SmartTRAK looks at the market’s response to the recently finalized...
This blog was originally posted on SmartTrak's website on December 31, 2024: https://blog.smarttrak.com/market-responds-to-final-mac-lcds. Reposted with permission. SmartTRAK looks at the market’s response to the recently finalized...
This blog was originally...
01/08/2025
Wounds
o
Clinician Commentary
Can NIRS Quantify How Much Oxygen Is Reaching a Wound?
12/02/2024
Jeesha Patel, DPM
Podiatry Today touched down with Jeesha Patel, DPM, a second-year resident at St. Vincent Hospital in Worcester, Massachusetts for highlights from the poster she co-authored at the Symposium on Advanced Wound Care Fall.
Podiatry Today touched down with Jeesha Patel, DPM, a second-year resident at St. Vincent Hospital in Worcester, Massachusetts for highlights from the poster she co-authored at the Symposium on Advanced Wound Care Fall.
Podiatry Today touched down with...
12/02/2024
Podiatry Today
Facing the Payback Crisis: Challenges Threatening Italy’s Medical Device Sector
Blog
Facing the Payback Crisis: Challenges Threatening Italy’s Medical Device Sector
11/26/2024
In an interview with SmartTRAK, Gennaro Broya de Lucia, president of the National Board of Directors at PMI Sanità, offers a comprehensive summary of the challenges for the medical device market in Italy, which places hundreds of companies at...
In an interview with SmartTRAK, Gennaro Broya de Lucia, president of the National Board of Directors at PMI Sanità, offers a comprehensive summary of the challenges for the medical device market in Italy, which places hundreds of companies at...
In an interview with SmartTRAK,...
11/26/2024
Wounds
Reimbursement Changes: Wound Dressings Under Threat in Germany
Blog
Reimbursement Changes: Wound Dressings Under Threat in Germany
10/01/2024
In an interview with SmartTRAK, Dr. Willi Schnorpfeil, an expert in reimbursement strategies, offers a comprehensive overview of the regulatory changes for advanced wound care products in Germany, which pose a potential threat to both market...
In an interview with SmartTRAK, Dr. Willi Schnorpfeil, an expert in reimbursement strategies, offers a comprehensive overview of the regulatory changes for advanced wound care products in Germany, which pose a potential threat to both market...
In an interview with SmartTRAK,...
10/01/2024
Wounds
Skin Substitute Market Rocked by DOJ Investigations
Blog
Skin Substitute Market Rocked by DOJ Investigations
08/08/2024
SmartTRAK believes the billions of dollars of Medicare abuse already uncovered is the tip of the iceberg in services billed to Medicare via the Physician Fee Schedule.
SmartTRAK believes the billions of dollars of Medicare abuse already uncovered is the tip of the iceberg in services billed to Medicare via the Physician Fee Schedule.
SmartTRAK believes the billions...
08/08/2024
Wounds
Medicare Administrative Contractors' (MACs) LCD Changes: Impact on Skin Substitutes/CTPs
Blog
Medicare Administrative Contractors' (MACs) LCD Changes: Impact on Skin Substitutes/CTPs
05/29/2024
All seven MACs, in a united front, released proposed changes to the LCDs, which govern Skin Substitute/CTP use for DFUs and VLUs. SmartTRAK looks at the potential impact on the market.
All seven MACs, in a united front, released proposed changes to the LCDs, which govern Skin Substitute/CTP use for DFUs and VLUs. SmartTRAK looks at the potential impact on the market.
All seven MACs, in a united...
05/29/2024
Wounds
Vaporox Company Spotlight
Blog
Vaporox Company Spotlight
05/07/2024
This blog was originally posted on SmartTrak's website on May 2, 2024: https://blog.smarttrak.com/vaporox-company-spotlight. Reposted with permission. New leadership at Vaporox to launch a second generation of vaporous hyperoxia...
This blog was originally posted on SmartTrak's website on May 2, 2024: https://blog.smarttrak.com/vaporox-company-spotlight. Reposted with permission. New leadership at Vaporox to launch a second generation of vaporous hyperoxia...
This blog was originally...
05/07/2024
Wounds
Swedish Wound Care Companies – You Win Some, You Lose Some
Blog
Swedish Wound Care Companies – You Win Some, You Lose Some
04/10/2024
This blog was originally posted on SmartTrak's website on April 2, 2024: https://blog.smarttrak.com/swedish-wound-care-companies-you-win-some-you-lose-some. Reposted with permission. It is difficult to make it as a small to midsize...
This blog was originally posted on SmartTrak's website on April 2, 2024: https://blog.smarttrak.com/swedish-wound-care-companies-you-win-some-you-lose-some. Reposted with permission. It is difficult to make it as a small to midsize...
This blog was originally...
04/10/2024
Wounds
Preview Image
Blog
What Impact will GLP-1 Agonists have on Chronic Wounds?
03/18/2024
With many believing that GLP-1 agonists should be considered a “wonder drug,” SmartTRAK explores what impact their use could have on the market for wound care
With many believing that GLP-1 agonists should be considered a “wonder drug,” SmartTRAK explores what impact their use could have on the market for wound care
With many believing that GLP-1...
03/18/2024
Wounds

SmartTRAK Wound Market Analyses

March 19:  SmartTRAK estimates the Global Advanced Wound Care market reached $14.7B in 2024 with the US accounting for 2/3 of that market as the US Skin Substitute revenue accounts for almost $7B of that number.

March 4: SmartTRAK estimates the 5-year CAGR (2019-2024E) for skin substitutes was +43% with the Mobile+ site of care growing from 1% to 49% during that time period. 

For more market analyses, click here.

Wound Care Updates

News
Imbed Biosciences
03/20/2025
Imbed Bio was granted IDE (Investigational Device Exemption) clearance for human testing of a synthetic matrix with gallium-silver ions designed to treat biofilm formation for normal wound healing.
Imbed Bio was granted IDE (Investigational Device Exemption) clearance for human testing of a synthetic matrix with gallium-silver ions designed to treat biofilm formation for normal wound healing.
Imbed Bio was granted IDE...
03/20/2025
Wounds
News
Organogenesis
03/20/2025
The interim analysis for the PuraPly AM clinical trial is expected in Q425 and will be published in Q126. After publication, it is hoped that PuraPly AM can be evaluated for coverage in the LCD. ORGO Q424 Earnings Transcripatiento onSeeking...
The interim analysis for the PuraPly AM clinical trial is expected in Q425 and will be published in Q126. After publication, it is hoped that PuraPly AM can be evaluated for coverage in the LCD. ORGO Q424 Earnings Transcripatiento onSeeking...
The interim analysis for the...
03/20/2025
Wounds
News
National Chronic Wound Registry
03/20/2025
In Singapore, data collected on chronic wounds and outcomes for a national wound registry from 812 patients found 20% were recurrent with VLUs, the highest at 30% over 6 months. The development of a national wound registry is both feasible...
In Singapore, data collected on chronic wounds and outcomes for a national wound registry from 812 patients found 20% were recurrent with VLUs, the highest at 30% over 6 months. The development of a national wound registry is both feasible...
In Singapore, data collected on...
03/20/2025
Wounds
News
Convatec
03/20/2025
Convatec reported that they are on-track to obtain EU regulatory approval for ConvaNiox, the new brand for their nitric oxide dressing. Approval is expected in H125, with product launch in 2026. CTEC FY24 Earnings Report
Convatec reported that they are on-track to obtain EU regulatory approval for ConvaNiox, the new brand for their nitric oxide dressing. Approval is expected in H125, with product launch in 2026. CTEC FY24 Earnings Report
Convatec reported that they are...
03/20/2025
Wounds
News
Smith+Nephew
03/20/2025
SNN’s Allevyn Life Sacrum Foam Dressing received “favorable” Evidence Bar ratings from ECRI for pressure injury prevention. ECRI is an independent and non-profit organization striving to improve the safety, quality and cost-effectiveness of...
SNN’s Allevyn Life Sacrum Foam Dressing received “favorable” Evidence Bar ratings from ECRI for pressure injury prevention. ECRI is an independent and non-profit organization striving to improve the safety, quality and cost-effectiveness of...
SNN’s Allevyn Life Sacrum Foam...
03/20/2025
Wounds
News
VHT - Vaporox, Inc
03/20/2025
A retrospective analysis of 40 chronic wound patients who received vaporous hyperoxia therapy (VHT) was published, showing 62% healing at 16 wks, including 74% of DFUs. VHT was shown to accelerate healing in wounds also treated with skin...
A retrospective analysis of 40 chronic wound patients who received vaporous hyperoxia therapy (VHT) was published, showing 62% healing at 16 wks, including 74% of DFUs. VHT was shown to accelerate healing in wounds also treated with skin...
A retrospective analysis of 40...
03/20/2025
Wounds
News
Aquacel Ag - Convatec
03/20/2025
SmartTRAK noted a 203-patient study finding CISEB dressing (Aquacel Ag+ Extra/Aquacel Ag Advantage) more effective than DACC (Cutimed Sorbact) for hard-to-heal VLUs, with a 35% higher likelihood of complete wound closure and faster...
SmartTRAK noted a 203-patient study finding CISEB dressing (Aquacel Ag+ Extra/Aquacel Ag Advantage) more effective than DACC (Cutimed Sorbact) for hard-to-heal VLUs, with a 35% higher likelihood of complete wound closure and faster...
SmartTRAK noted a 203-patient...
03/20/2025
Wounds
News
NexoBrid - MediWound
03/20/2025
MediWound announces the publication of its Phase III Children Innovative Debridement Study (CIDS) for pediatric burns. The study findings reinforce NexoBrid’s clinical benefits as a rapid, effective and non-surgical alternative for eschar...
MediWound announces the publication of its Phase III Children Innovative Debridement Study (CIDS) for pediatric burns. The study findings reinforce NexoBrid’s clinical benefits as a rapid, effective and non-surgical alternative for eschar...
MediWound announces the...
03/20/2025
Wounds
News
NPseal - Guard Medical
03/20/2025
A study of 40 patients with 80 incisions received NPseals on one incision vs standard dressing on the other found that overall scores for scar spread, erythema, dyspigmentation, scar hypertrophy and overall impression were lower in the study...
A study of 40 patients with 80 incisions received NPseals on one incision vs standard dressing on the other found that overall scores for scar spread, erythema, dyspigmentation, scar hypertrophy and overall impression were lower in the study...
A study of 40 patients with 80...
03/20/2025
Wounds
News
SkinTE - PolarityTE
03/20/2025
Polarity announces SkinTE has received Breakthrough Therapy Designation (BTD) from the FDA for the treatment of Wagner Grade 1 DFUs based on key positive data from its Phase II study. The designation provides access to expedited development...
Polarity announces SkinTE has received Breakthrough Therapy Designation (BTD) from the FDA for the treatment of Wagner Grade 1 DFUs based on key positive data from its Phase II study. The designation provides access to expedited development...
Polarity announces SkinTE has...
03/20/2025
Wounds
News
Imbed Biosciences
03/20/2025
Imbed Bio was granted IDE (Investigational Device Exemption) clearance for human testing of a synthetic matrix with gallium-silver ions designed to treat biofilm formation for normal wound healing.
Imbed Bio was granted IDE (Investigational Device Exemption) clearance for human testing of a synthetic matrix with gallium-silver ions designed to treat biofilm formation for normal wound healing.
Imbed Bio was granted IDE...
03/20/2025
Wounds
News
Organogenesis
03/20/2025
The interim analysis for the PuraPly AM clinical trial is expected in Q425 and will be published in Q126. After publication, it is hoped that PuraPly AM can be evaluated for coverage in the LCD. ORGO Q424 Earnings Transcripatiento onSeeking...
The interim analysis for the PuraPly AM clinical trial is expected in Q425 and will be published in Q126. After publication, it is hoped that PuraPly AM can be evaluated for coverage in the LCD. ORGO Q424 Earnings Transcripatiento onSeeking...
The interim analysis for the...
03/20/2025
Wounds
News
National Chronic Wound Registry
03/20/2025
In Singapore, data collected on chronic wounds and outcomes for a national wound registry from 812 patients found 20% were recurrent with VLUs, the highest at 30% over 6 months. The development of a national wound registry is both feasible...
In Singapore, data collected on chronic wounds and outcomes for a national wound registry from 812 patients found 20% were recurrent with VLUs, the highest at 30% over 6 months. The development of a national wound registry is both feasible...
In Singapore, data collected on...
03/20/2025
Wounds
News
Convatec
03/20/2025
Convatec reported that they are on-track to obtain EU regulatory approval for ConvaNiox, the new brand for their nitric oxide dressing. Approval is expected in H125, with product launch in 2026. CTEC FY24 Earnings Report
Convatec reported that they are on-track to obtain EU regulatory approval for ConvaNiox, the new brand for their nitric oxide dressing. Approval is expected in H125, with product launch in 2026. CTEC FY24 Earnings Report
Convatec reported that they are...
03/20/2025
Wounds
News
Smith+Nephew
03/20/2025
SNN’s Allevyn Life Sacrum Foam Dressing received “favorable” Evidence Bar ratings from ECRI for pressure injury prevention. ECRI is an independent and non-profit organization striving to improve the safety, quality and cost-effectiveness of...
SNN’s Allevyn Life Sacrum Foam Dressing received “favorable” Evidence Bar ratings from ECRI for pressure injury prevention. ECRI is an independent and non-profit organization striving to improve the safety, quality and cost-effectiveness of...
SNN’s Allevyn Life Sacrum Foam...
03/20/2025
Wounds
News
VHT - Vaporox, Inc
03/20/2025
A retrospective analysis of 40 chronic wound patients who received vaporous hyperoxia therapy (VHT) was published, showing 62% healing at 16 wks, including 74% of DFUs. VHT was shown to accelerate healing in wounds also treated with skin...
A retrospective analysis of 40 chronic wound patients who received vaporous hyperoxia therapy (VHT) was published, showing 62% healing at 16 wks, including 74% of DFUs. VHT was shown to accelerate healing in wounds also treated with skin...
A retrospective analysis of 40...
03/20/2025
Wounds
News
Aquacel Ag - Convatec
03/20/2025
SmartTRAK noted a 203-patient study finding CISEB dressing (Aquacel Ag+ Extra/Aquacel Ag Advantage) more effective than DACC (Cutimed Sorbact) for hard-to-heal VLUs, with a 35% higher likelihood of complete wound closure and faster...
SmartTRAK noted a 203-patient study finding CISEB dressing (Aquacel Ag+ Extra/Aquacel Ag Advantage) more effective than DACC (Cutimed Sorbact) for hard-to-heal VLUs, with a 35% higher likelihood of complete wound closure and faster...
SmartTRAK noted a 203-patient...
03/20/2025
Wounds
News
NexoBrid - MediWound
03/20/2025
MediWound announces the publication of its Phase III Children Innovative Debridement Study (CIDS) for pediatric burns. The study findings reinforce NexoBrid’s clinical benefits as a rapid, effective and non-surgical alternative for eschar...
MediWound announces the publication of its Phase III Children Innovative Debridement Study (CIDS) for pediatric burns. The study findings reinforce NexoBrid’s clinical benefits as a rapid, effective and non-surgical alternative for eschar...
MediWound announces the...
03/20/2025
Wounds
News
NPseal - Guard Medical
03/20/2025
A study of 40 patients with 80 incisions received NPseals on one incision vs standard dressing on the other found that overall scores for scar spread, erythema, dyspigmentation, scar hypertrophy and overall impression were lower in the study...
A study of 40 patients with 80 incisions received NPseals on one incision vs standard dressing on the other found that overall scores for scar spread, erythema, dyspigmentation, scar hypertrophy and overall impression were lower in the study...
A study of 40 patients with 80...
03/20/2025
Wounds
News
SkinTE - PolarityTE
03/20/2025
Polarity announces SkinTE has received Breakthrough Therapy Designation (BTD) from the FDA for the treatment of Wagner Grade 1 DFUs based on key positive data from its Phase II study. The designation provides access to expedited development...
Polarity announces SkinTE has received Breakthrough Therapy Designation (BTD) from the FDA for the treatment of Wagner Grade 1 DFUs based on key positive data from its Phase II study. The designation provides access to expedited development...
Polarity announces SkinTE has...
03/20/2025
Wounds

About This Partnership

Wounds has partnered with SmartTRAK, the global leader in business intelligence for the life sciences industry, to provide market data and analyses in wound care.  Through rich ongoing updates and comprehensive expert analyses, wound care professionals will stay ahead of evolving market trends and conditions of interest to the wound care community.

For more information on SmartTRAK resources and services, click here.

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use